Dr. Victoria Forte has been appointed chief of the Division of Hematology/Oncology, Cancer Service Line director, and ...

The FDA approved two oncology regimens on Jan. 16.One is for a subset of patients with colorectal cancer and the other for ...

The American Cancer Society projected approximately 2 million new cancer diagnoses and 618,000 new cancer deaths in the U.S.

Adjuvant ado-trastuzumab emtansine significantly prolonged survival compared with trastuzumab for certain women with ...

An affiliate of a major developer has bought land near Crossgates where there's a plan to build a regional cancer treatment ...

More Than 40 Adult Sickle Cell Disease Patients Now Enrolled in BEACON Trial of BEAM-101; Beam Expects to Dose 30 Patients and Present Updated ...

St. Francis Hospital’s internal medicine residency program received its first fellowship training matches. MD, MSC Andrew ...

Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and ...

Kite Pharma is flying high with the addition of a new member to its senior leadership team. | Kite Pharma is flying high with ...

Rachna Shroff, MD, is the associate director of clinical investigations at the U of A Cancer Center and a professor and chief ...

TScan Therapeutics Inc. (NASDAQ:TCRX), a clinical-stage biopharmaceutical company with a market capitalization of $139.57 million, is poised at a critical juncture in its development of innovative ...

The FDA has banned Red Dye No. 3, citing cancer risk concerns. The removal from the supply chain may take over a year, raising questions about other additives.